Patents by Inventor Matthew Beaudet
Matthew Beaudet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230384227Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: ApplicationFiled: March 15, 2023Publication date: November 30, 2023Inventors: Matthew BEAUDET, Jill HENDRICKSON, David HAGEN, Rich MEYER
-
Patent number: 11635383Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: GrantFiled: March 24, 2021Date of Patent: April 25, 2023Inventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
-
Publication number: 20220042915Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: ApplicationFiled: March 24, 2021Publication date: February 10, 2022Inventors: Matthew BEAUDET, Jill HENDRICKSON, David HAGEN, Rich MEYER
-
Patent number: 10962480Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: GrantFiled: January 7, 2020Date of Patent: March 30, 2021Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
-
Publication number: 20200292456Abstract: Devices and methods for measuring the quantity of multiple analytes in a sample can include a device designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and machine executable instructions configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: ApplicationFiled: January 7, 2020Publication date: September 17, 2020Inventors: Matthew BEAUDET, Jill HENDRICKSON, David HAGEN, Rich MEYER
-
Patent number: 10533946Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: GrantFiled: March 15, 2018Date of Patent: January 14, 2020Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
-
Publication number: 20180335386Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: ApplicationFiled: March 15, 2018Publication date: November 22, 2018Inventors: Matthew BEAUDET, Jill HENDRICKSON, David HAGEN, Rich MEYER
-
Patent number: 9964490Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: GrantFiled: September 11, 2015Date of Patent: May 8, 2018Assignee: Life Technologies CorporationInventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
-
Publication number: 20160003743Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: ApplicationFiled: September 11, 2015Publication date: January 7, 2016Inventors: Matthew Beaudet, Jill HENDRICKSON, David HAGEN, Rich MEYER
-
Publication number: 20150247799Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.Type: ApplicationFiled: March 2, 2015Publication date: September 3, 2015Inventors: Matthew BEAUDET, William COX, Stephen YUE
-
Patent number: 8969004Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.Type: GrantFiled: May 15, 2013Date of Patent: March 3, 2015Assignee: Life Technologies CorporationInventors: Matthew Beaudet, William Gregory Cox, Stephen Yue
-
Publication number: 20140076726Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.Type: ApplicationFiled: May 15, 2013Publication date: March 20, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Matthew BEAUDET, William Gregory Cox, Stephen Yue
-
Publication number: 20140011191Abstract: The present invention relates to devices and methods for measuring the quantity of multiple analytes in a sample. The device is designed such that each of the analyte sensing elements is configured to measure the quantity of a predetermined analyte and where the machine executable instructions are configured to select the proper analyte sensing element corresponding to the analyte to be measured.Type: ApplicationFiled: September 4, 2013Publication date: January 9, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Matthew Beaudet, Jill Hendrickson, David Hagen, Rich Meyer
-
Patent number: 8562802Abstract: Cassette electrophoresis systems that allow viewing of molecules during the electrophoresis run are disclosed. Cassette electrophoresis bases that reversibly engage light sources, such as light source bases are disclosed. Also disclosed are visible light transillumination systems for viewing a pattern of fluorescence emitted by fluorophores comprising a cassette housing fluorophore-containing material and a base unit to support the cassette. In some aspects the base unit that includes a power supply also houses a light source having output in the visible wavelength region and a filter placed between the light source and the fluorophores. The system is constructed and arranged such that patterns of fluorescence emitted by the fluorophores are viewable. Also described are charging devices for providing charge to gel electrophoresis systems, portable gel electrophoresis systems and methods of use thereof.Type: GrantFiled: August 19, 2011Date of Patent: October 22, 2013Assignee: Life Technologies CorporationInventors: Matthew Beaudet, Ilana Margalit, Ronen Benarieh, Andres Wainstein, Gustavo Turkieltaub
-
Patent number: 7977057Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.Type: GrantFiled: April 30, 2010Date of Patent: July 12, 2011Assignee: Life Technologies CorporationInventors: Matthew Beaudet, Gregory Cox, Stephen Yue
-
Publication number: 20050239096Abstract: The present invention provides methods for determining the presence of immobilized nucleic acid employing unsymmetrical cyanine dyes that are derivatives of thiazole orange, a staining solution and select fluorogenic compounds that are characterized as being essentially non-genotoxic. The methods comprise immobilizing nucleic acid, single or double stranded DNA, RNA or a combination thereof, on a solid or semi solid support, contacting the immobilized nucleic acid with an unsymmetrical cyanine dye compound and then illuminating the immobilized nucleic acid with an appropriate wavelength whereby the presence of the nucleic acid is determined. The cyanine dye compounds are typically present in an aqueous staining solution comprising the dye compound and a tris acetate or tris borate buffer wherein the solution facilitates the contact of the dye compound and the immobilized nucleic acid.Type: ApplicationFiled: September 30, 2004Publication date: October 27, 2005Inventors: Matthew Beaudet, W. Cox, Stephen Yue